What Are the Risks of Insufficient Glucose Monitoring during Tesamorelin Therapy?
Insufficient glucose monitoring during Tesamorelin therapy risks silent progression to hyperglycemia by masking GH-induced insulin resistance.
HRTioAugust 1, 2025